Point72 Hong Kong LTD Amgen Inc Call Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.19 Million - $1.34 Million	-5,300 Reduced 42.4%	7,200 $1.62 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $3.67 Million - $4.08 Million	-15,900 Reduced 55.99%	12,500 $3.04 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $2.28 Million - $2.52 Million	10,400 Added 57.78%	28,400 $6.87 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $1.33 Million - $1.52 Million	-6,700 Reduced 27.13%	18,000 $4.05 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $1.02 Million - $1.19 Million	4,800 Added 24.12%	24,700 $5.25 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $2.62 Million - $2.9 Million	11,200 Added 128.74%	19,900 $4.85 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $2.17 Million - $2.53 Million	-9,800 Reduced 52.97%	8,700 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $4 Million - $4.77 Million	18,500 New	18,500 $4.25 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.